Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

HCA vs THC

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
HCA
HCA Healthcare, Inc.

Medical - Care Facilities

HealthcareNYSE • US
Market Cap$95.86B
5Y Perf.+301.1%
THC
Tenet Healthcare Corporation

Medical - Care Facilities

HealthcareNYSE • US
Market Cap$16.37B
5Y Perf.+759.0%

HCA vs THC — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
HCA logoHCA
THC logoTHC
IndustryMedical - Care FacilitiesMedical - Care Facilities
Market Cap$95.86B$16.37B
Revenue (TTM)$75.60B$21.45B
Net Income (TTM)$6.78B$1.70B
Gross Margin41.5%42.8%
Operating Margin15.8%16.1%
Forward P/E14.2x10.5x
Total Debt$50.20B$13.17B
Cash & Equiv.$1.04B$2.88B

HCA vs THCLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

HCA
THC
StockMay 20May 26Return
HCA Healthcare, Inc. (HCA)100401.1+301.1%
Tenet Healthcare Co… (THC)100859.0+759.0%

Price return only. Dividends and distributions are not included.

Quick Verdict: HCA vs THC

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: HCA leads in 5 of 7 categories, making it the strongest pick for growth and revenue expansion and profitability and margin quality. Tenet Healthcare Corporation is the stronger pick specifically for valuation and capital efficiency and recent price momentum and sentiment. As sector peers, any of these can serve as alternatives in the same allocation.
HCA
HCA Healthcare, Inc.
The Income Pick

HCA carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.

  • Dividend streak 5 yrs, beta 0.29, yield 0.7%
  • Rev growth 7.1%, EPS growth 29.0%, 3Y rev CAGR 7.9%
  • Lower volatility, beta 0.29, current ratio 0.83x
Best for: income & stability and growth exposure
THC
Tenet Healthcare Corporation
The Long-Run Compounder

THC is the clearest fit if your priority is long-term compounding and valuation efficiency.

  • 491.5% 10Y total return vs HCA's 452.6%
  • PEG 0.32 vs HCA's 0.67
  • Lower P/E (10.5x vs 14.2x), PEG 0.32 vs 0.67
Best for: long-term compounding and valuation efficiency
See the full category breakdown
CategoryWinnerWhy
GrowthHCA logoHCA7.1% revenue growth vs THC's 3.1%
ValueTHC logoTHCLower P/E (10.5x vs 14.2x), PEG 0.32 vs 0.67
Quality / MarginsHCA logoHCA9.0% margin vs THC's 7.9%
Stability / SafetyHCA logoHCABeta 0.29 vs THC's 0.71
DividendsHCA logoHCA0.7% yield; 5-year raise streak; the other pay no meaningful dividend
Momentum (1Y)THC logoTHC+25.4% vs HCA's +23.6%
Efficiency (ROA)HCA logoHCA11.3% ROA vs THC's 5.7%, ROIC 19.9% vs 13.2%

HCA vs THC — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

HCAHCA Healthcare, Inc.
FY 2025
Managed Care And Other Insurers
50.5%$37.0B
Managed Medicare
18.4%$13.4B
Medicare
15.4%$11.3B
Medicaid
8.1%$5.9B
Managed Medicaid
5.0%$3.7B
International
2.5%$1.9B
THCTenet Healthcare Corporation
FY 2025
Ambulatory Care
50.2%$5.2B
Hospital Operations
49.8%$5.1B

HCA vs THC — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLHCALAGGINGTHC

Income & Cash Flow (Last 12 Months)

THC leads this category, winning 4 of 6 comparable metrics.

HCA is the larger business by revenue, generating $75.6B annually — 3.5x THC's $21.5B. Profitability is closely matched — net margins range from 9.0% (HCA) to 7.9% (THC). On growth, HCA holds the edge at +6.7% YoY revenue growth, suggesting stronger near-term business momentum.

MetricHCA logoHCAHCA Healthcare, I…THC logoTHCTenet Healthcare …
RevenueTrailing 12 months$75.6B$21.5B
EBITDAEarnings before interest/tax$15.5B$4.3B
Net IncomeAfter-tax profit$6.8B$1.7B
Free Cash FlowCash after capex$7.7B$3.3B
Gross MarginGross profit ÷ Revenue+41.5%+42.8%
Operating MarginEBIT ÷ Revenue+15.8%+16.1%
Net MarginNet income ÷ Revenue+9.0%+7.9%
FCF MarginFCF ÷ Revenue+10.2%+15.6%
Rev. Growth (YoY)Latest quarter vs prior year+6.7%+2.8%
EPS Growth (YoY)Latest quarter vs prior year+44.6%+87.6%
THC leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

THC leads this category, winning 6 of 6 comparable metrics.

At 12.1x trailing earnings, THC trades at a 20% valuation discount to HCA's 15.1x P/E. Adjusting for growth (PEG ratio), THC offers better value at 0.37x vs HCA's 0.72x — a lower PEG means you pay less per unit of expected earnings growth.

MetricHCA logoHCAHCA Healthcare, I…THC logoTHCTenet Healthcare …
Market CapShares × price$95.9B$16.4B
Enterprise ValueMkt cap + debt − cash$145.0B$26.7B
Trailing P/EPrice ÷ TTM EPS15.11x12.07x
Forward P/EPrice ÷ next-FY EPS est.14.18x10.53x
PEG RatioP/E ÷ EPS growth rate0.72x0.37x
EV / EBITDAEnterprise value multiple9.36x6.20x
Price / SalesMarket cap ÷ Revenue1.27x0.77x
Price / BookPrice ÷ Book value/share1.89x
Price / FCFMarket cap ÷ FCF12.46x6.47x
THC leads this category, winning 6 of 6 comparable metrics.

Profitability & Efficiency

HCA leads this category, winning 4 of 6 comparable metrics.
MetricHCA logoHCAHCA Healthcare, I…THC logoTHCTenet Healthcare …
ROE (TTM)Return on equity+19.6%
ROA (TTM)Return on assets+11.3%+5.7%
ROICReturn on invested capital+19.9%+13.2%
ROCEReturn on capital employed+27.0%+13.8%
Piotroski ScoreFundamental quality 0–977
Debt / EquityFinancial leverage1.47x
Net DebtTotal debt minus cash$49.2B$10.3B
Cash & Equiv.Liquid assets$1.0B$2.9B
Total DebtShort + long-term debt$50.2B$13.2B
Interest CoverageEBIT ÷ Interest expense5.37x4.28x
HCA leads this category, winning 4 of 6 comparable metrics.

Total Returns (Dividends Reinvested)

THC leads this category, winning 6 of 6 comparable metrics.

A $10,000 investment in THC five years ago would be worth $29,145 today (with dividends reinvested), compared to $21,226 for HCA. Over the past 12 months, THC leads with a +25.4% total return vs HCA's +23.6%. The 3-year compound annual growth rate (CAGR) favors THC at 39.2% vs HCA's 16.3% — a key indicator of consistent wealth creation.

MetricHCA logoHCAHCA Healthcare, I…THC logoTHCTenet Healthcare …
YTD ReturnYear-to-date-8.7%-6.3%
1-Year ReturnPast 12 months+23.6%+25.4%
3-Year ReturnCumulative with dividends+57.1%+169.5%
5-Year ReturnCumulative with dividends+112.3%+191.5%
10-Year ReturnCumulative with dividends+452.6%+491.5%
CAGR (3Y)Annualised 3-year return+16.3%+39.2%
THC leads this category, winning 6 of 6 comparable metrics.

Risk & Volatility

HCA leads this category, winning 2 of 2 comparable metrics.

HCA is the less volatile stock with a 0.29 beta — it tends to amplify market swings less than THC's 0.71 beta. A beta below 1.0 means the stock typically moves less than the S&P 500.

MetricHCA logoHCAHCA Healthcare, I…THC logoTHCTenet Healthcare …
Beta (5Y)Sensitivity to S&P 5000.29x0.71x
52-Week HighHighest price in past year$556.52$247.21
52-Week LowLowest price in past year$330.00$146.31
% of 52W HighCurrent price vs 52-week peak+77.0%+75.6%
RSI (14)Momentum oscillator 0–10029.244.6
Avg Volume (50D)Average daily shares traded1.0M1.2M
HCA leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

HCA leads this category, winning 1 of 1 comparable metric.

Wall Street rates HCA as "Buy" and THC as "Buy". Consensus price targets imply 43.4% upside for THC (target: $268) vs 23.0% for HCA (target: $527). HCA is the only dividend payer here at 0.69% yield — a key consideration for income-focused portfolios.

MetricHCA logoHCAHCA Healthcare, I…THC logoTHCTenet Healthcare …
Analyst RatingConsensus buy/hold/sellBuyBuy
Price TargetConsensus 12-month target$527.45$268.00
# AnalystsCovering analysts4632
Dividend YieldAnnual dividend ÷ price+0.7%
Dividend StreakConsecutive years of raises50
Dividend / ShareAnnual DPS$2.94
Buyback YieldShare repurchases ÷ mkt cap+10.5%+8.8%
HCA leads this category, winning 1 of 1 comparable metric.
Key Takeaway

THC leads in 3 of 6 categories (Income & Cash Flow, Valuation Metrics). HCA leads in 3 (Profitability & Efficiency, Risk & Volatility).

Best OverallHCA Healthcare, Inc. (HCA)Leads 3 of 6 categories
Loading custom metrics...

HCA vs THC: Frequently Asked Questions

10 questions · data-driven answers · updated daily

01

Is HCA or THC a better buy right now?

For growth investors, HCA Healthcare, Inc.

(HCA) is the stronger pick with 7. 1% revenue growth year-over-year, versus 3. 1% for Tenet Healthcare Corporation (THC). Tenet Healthcare Corporation (THC) offers the better valuation at 12. 1x trailing P/E (10. 5x forward), making it the more compelling value choice. Analysts rate HCA Healthcare, Inc. (HCA) a "Buy" — based on 46 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — HCA or THC?

On trailing P/E, Tenet Healthcare Corporation (THC) is the cheapest at 12.

1x versus HCA Healthcare, Inc. at 15. 1x. On forward P/E, Tenet Healthcare Corporation is actually cheaper at 10. 5x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Tenet Healthcare Corporation wins at 0. 32x versus HCA Healthcare, Inc. 's 0. 67x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

03

Which is the better long-term investment — HCA or THC?

Over the past 5 years, Tenet Healthcare Corporation (THC) delivered a total return of +191.

5%, compared to +112. 3% for HCA Healthcare, Inc. (HCA). Over 10 years, the gap is even starker: THC returned +491. 5% versus HCA's +452. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — HCA or THC?

By beta (market sensitivity over 5 years), HCA Healthcare, Inc.

(HCA) is the lower-risk stock at 0. 29β versus Tenet Healthcare Corporation's 0. 71β — meaning THC is approximately 147% more volatile than HCA relative to the S&P 500.

05

Which is growing faster — HCA or THC?

By revenue growth (latest reported year), HCA Healthcare, Inc.

(HCA) is pulling ahead at 7. 1% versus 3. 1% for Tenet Healthcare Corporation (THC). On earnings-per-share growth, the picture is similar: HCA Healthcare, Inc. grew EPS 29. 0% year-over-year, compared to -52. 6% for Tenet Healthcare Corporation. Over a 3-year CAGR, HCA leads at 7. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — HCA or THC?

HCA Healthcare, Inc.

(HCA) is the more profitable company, earning 9. 0% net margin versus 6. 6% for Tenet Healthcare Corporation — meaning it keeps 9. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: THC leads at 16. 1% versus 15. 8% for HCA. At the gross margin level — before operating expenses — THC leads at 82. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is HCA or THC more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Tenet Healthcare Corporation (THC) is the more undervalued stock at a PEG of 0. 32x versus HCA Healthcare, Inc. 's 0. 67x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Tenet Healthcare Corporation (THC) trades at 10. 5x forward P/E versus 14. 2x for HCA Healthcare, Inc. — 3. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for THC: 43. 4% to $268. 00.

08

Which pays a better dividend — HCA or THC?

In this comparison, HCA (0.

7% yield) pays a dividend. THC does not pay a meaningful dividend and should not be held primarily for income.

09

Is HCA or THC better for a retirement portfolio?

For long-horizon retirement investors, HCA Healthcare, Inc.

(HCA) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 29), 0. 7% yield, +452. 6% 10Y return). Both have compounded well over 10 years (HCA: +452. 6%, THC: +491. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between HCA and THC?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

HCA pays a dividend while THC does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

HCA

Stable Dividend Mega-Cap

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 5%
Run This Screen
Stocks Like

THC

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Net Margin > 5%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform HCA and THC on the metrics below

Revenue Growth>
%
(HCA: 6.7% · THC: 2.8%)
Net Margin>
%
(HCA: 9.0% · THC: 7.9%)
P/E Ratio<
x
(HCA: 15.1x · THC: 12.1x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.